No Detail Found!

Outcomes of Hepatic Venoplasty in Budd-Chiari Syndrome

Author(s)
Adnan Salim Department of Gastroenterology and Hepatology, Shaikh Zayed Hospital,Lahore,Pakistan
Khurram Shafique Department of Radiology, Shaikh Zayed Medical Complex,Lahore,Pakistan
Sadia Jabbar Department of Gastroenterology, Lahore General Hospital,Lahore,Pakistan
Zia Ur Rehman Department of Gastroenterology and Hepatology, Shaikh Zayed Hospital,Lahore,Pakistan
Kashif Malik Department of Gastroenterology and Hepatology, Shaikh Zayed Hospital,Lahore,Pakistan
Abstract
To observe medium to long-term outcomes of hepatic venoplasty in patients with Budd-Chiari syndrome (BCS). Study Design: An observational study. Place and Duration of the Study: Department of Gastroenterology and Radiology, Shaikh Zayed Hospital, Lahore, Pakistan, from February 2021 to December 2022. Methodology: After obtaining ethical approval, adult patients presenting to the authors Institute with BCS and candidates for venoplasty were recruited. After the procedure, they were followed up for twelve months. Results: Twenty- ve patients were recruited including 18 (72%) males and 7 (28%) females. Vascular occlusion was due to identi ed hypercoagulable state in 11 (44%) and idiopathic in 14 (56%). Eight (32%) patients had liver cirrhosis. Ascites was present in 24 (96%) patients prior to venoplasty. Twenty-one (84%) patients had varices. Stage of liver disease was child A in 5 (20%), B in 16 (64%), and C in 4 (16%). Vascular blockage involved all hepatic veins in nearly a quarter of patients. Vascular stenting post-venoplasty was done in 18 (72%). All patients received warfarin (target INR 2-2.5). Twelve months after venoplasty, 4 (16%) patients had undergone liver transplantation, 4 (16%) lost to follow up, and 6 (24%) had expired due to cirrhosis-related complications. In the remaining 11 (44%), hepatic veins were patent in 10 (40%) and blocked in 1 (4%). One (4%) patient had signi cant ascites, whereas signi cant-sized varices were noted in 2 (8%). Conclusion: Venoplasty results in good long-term outcomes in patients with BCS if they have not developed advanced cirrhosis. In patients with cirrhosis, outcomes are suboptimal and liver transplantation remains the only curative option. This highlights the importance of early detection and specialist centre referral before cirrhosis develops.
Publication Details
Page(s) 452-456
Published Journal: Journal of the College of Physicians and Surgeons Pakistan, Volume: 35, Issue: 04, Year: 2025

Request the full text from PASTIC

Keywords
Cirrhosis, Budd-Chiari syndrome, Venoplasty
References
Zu M,Xu H,Zhang Q,Gu Y,Wei N,Xu W .2020 .Review of Budd-Chiari syndrome. J Int Med, 03(2) : 65-76.
Lupasco I,Dumbrava VT .2021 .Diagnosis and therapy of BuddChiari syndrome. Med Pharm Rep, 10(Suppl No 1) : S68-71.
Ida M,Arai K,Yoshikawa J,Takayama S,Miyamori H,Toya T .1986 .Therapeutic hepatic vein angioplasty for Budd-Chiari syndrome. Cardiovasc Intervent Radiol, 10(4) : 187-90.
Sparano J,Chang J,Trasi S,Bonanno C .1987 .Treatment of the Budd-Chiari syndrome with percutaneous transluminal angioplasty. Case report and review of the literature. Am J Med, 10(87) : 90022-2.
Eapen CE,Velissaris D,Heydtmann M,Gunson B,Olli S,Elias E. .2005 .Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome. Gut, 071423(6) : 878-84.
Tasneem AA,Soomro GB,Abbas Z,Luck NH,Hassan SM. .2015 .Clinical presentation and predictors of survival in patients with Budd-Chiari syndrome: Experience from a tertiary care hospital in Pakistan. J Pak Med Assoc, 65(2) : 120-4.
Tripathi D,Sunderraj L,Vemala V,Mehrzad H,Zia Z,Mangat K .2017 .Long-term outcomes following percutaneous hepatic vein recanalisation for Budd-Chiari syndrome. Liver Int, 10(1) : 111-20.
Malik N,Bhatti AM,Husssain SM,Mansoor J,Saeed F. .2014 .The Budd-Chiari syndrome: A 22-year male treated successfully with mesocaval shunt. J Pak Med Assoc, 64(5) : 599-600.
Cheng DL,Xu H,Li CL,Lv WF,Li CT,Mukhiya G .2019 .Interventional treatment strategy for primary Budd-Chiari syndrome with both inferior vena cava and hepatic vein involvement: Patients from two centers in China. Cardiovasc Intervent Radiol, 10(9) : 1311-21.
Mukhiya G,Jiao D,Han X,Zhou X,Pokhrel G .2022 .Survival and clinical success of endovascular intervention in patients with Budd-Chiari syndrome: A systematic review. J Clin Imaging Sci, 10 : .
Hemachandran N,Acharya S,Kedia S,Gunjan D,Saraya A .2020 .Long-term outcomes of endovascular interventions in more than 500 patients with Budd-Chiari syndrome. J Vasc Interv Radiol, 08(1) : 61-9.
Chen ZK,Fan J,Cao C,Li Y. .2018 .Endovascular treatment for hepatic vein-type Budd-Chiari syndrome: E ectiveness and long-term outcome. Radiol Med, 10(10) : 799-807.
Patidar Y,Pal CK,Mukund A,Kumar G,Sarin SK .2021 .Retrospective comparative study of e cacy, safety and outcome of percutaneous intervention for Budd-Chiari syndrome patients with bilirubin less than 3 and 3-6 mg/dl. Br J Radiol, 10(1120) : 20201157.
Baray F,Noori MB,Aram MM,Hamidi H .2021 .Misdiagnosis of Budd-Chiari syndrome. a case report from Afghanistan. Ann Med, 103218 : 103218.
0

Citations

0

Downloads

86

Views